Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Open-market sale President & CEO sold 6,124 shares at $0.67 ($4,112)
  2. 4 Open-market sale GRAMMER ELIZABETH A sold 1,263 shares at $0.67 ($848)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale Chief Financial Officer sold 1,800 shares at $0.67 ($1,206)
  5. 4 Open-market sale Blanks Robert sold 1,752 shares at $0.67 ($1,174)
  6. 4 Open-market sale President & CEO sold 6,229 shares at $0.67 ($4,173)
  7. 4 Open-market sale GRAMMER ELIZABETH A sold 1,528 shares at $0.67 ($1,024)
  8. 4 Open-market sale Chief Development Officer sold 2,353 shares at $0.67 ($1,577)
  9. 4 Open-market sale Chief Commercial Officer sold 3,400 shares at $0.67 ($2,278)
  10. 4 Grant or award Chief Development Officer acquired 55,000 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 42,000 shares (grant or award)
  12. 4 Grant or award Chief Commercial Officer acquired 141,000 shares (grant or award)
  13. 4 Grant or award Blanks Robert acquired 40,000 shares (grant or award)
  14. 4 Grant or award GRAMMER ELIZABETH A acquired 42,000 shares (grant or award)
  15. 4 Grant or award President & CEO acquired 150,000 shares (grant or award)
  16. 4 Open-market sale 10% owner sold 2,881,570 shares at an average $1.26 ($3,642,572)
  17. 4 Open-market sale 10% owner sold 2,881,570 shares at an average $1.26 ($3,642,572)
  18. 4 Open-market sale Chief Development Officer sold 827 shares at an average $0.99 ($820)
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 16 of 35 · 696 filings